Inyx, Inc.
801 Brickell Avenue, 9th Floor
Miami
Florida
33131
United States
Tel: 305-789-6649
Fax: 305-372-0189
Website: http://www.inyxinc.com/
Email: info@inyxinc.com
37 articles about Inyx, Inc.
-
Former Inyx CEO Charged in $100 Million Fraud Scheme
10/3/2016
-
Inyx, Inc. Chairman & CEO Approved as Debtor-In-Possession Lender for Inyx Subsidiaries
7/12/2007
-
Buyout Group Reaffirms $3.01 Per Share All-Cash, Go-Private Offer For Inyx, Inc.
4/16/2007
-
$3.01 Per Share All-Cash, Go-Private Offer for Inyx, Inc.
3/26/2007
-
Inyx, Inc. Reports Update on Corporate Matters
3/19/2007
-
Inyx, Inc.'s Ashton Subsidiary To Manufacture And Package Prescription Product For Acorus Therapeutics
1/31/2007
-
Inyx, Inc. Reports Update On Corporate Matters
1/25/2007
-
Inyx, Inc. And BioProgress plc Form Strategic Collaboration
12/21/2006
-
Generex Biotechnology Corporation Selects Inyx, Inc. To Produce Glucose RapidSpray(TM) For Worldwide Markets
12/7/2006
-
Inyx, Inc. Reports Third-Quarter Operating Results
12/4/2006
-
Inyx, Inc. Reports Management-Led Group Has Approached Board About Going Private; Other Material Developments Reported
11/27/2006
-
Inyx, Inc. Signs Deal With Plethora Solutions Holdings To Produce Novel HFA Aerosol Indicated For The Treatment Of Premature Ejaculation For Clinical Trial In The United States
11/2/2006
-
Inyx, Inc. To Acquire Pharmapac UK Ltd. For Approximately $17 Million
9/28/2006
-
Inyx, Inc. Completes Acquisition Of 6 Eye-Care Products From Advanced Medical Optics, Inc.
9/11/2006
-
Inyx, Inc. Announces Election Of Two New Outside Directors At Its Annual Meeting
8/24/2006
-
Inyx, Inc. Reports Second-Quarter Operating Results
8/22/2006
-
Inyx, Inc. To Acquire 6 Eye-Care Products From Advanced Medical Optics, Inc.
8/7/2006
-
Inyx, Inc. Selected By U.K. Client To Produce Novel HFA Aerosol Urological Product For U.S. Phase III Trial
7/20/2006
-
Inyx, Inc. Announces Annual Meeting Will Be August 24 For Shareholders Of Record As Of July 26
7/18/2006
-
Inyx, Inc.'s Ashton Pharmaceuticals Selected To Produce Generic Drugs For European Markets
7/17/2006